AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33303553 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin challenge test with self-suppression attempts (CS5) for COPD with chronic cough (n=16)
Number of subjects: 27
Study 33303553 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin challenge test with self-suppression attempts (CS5) for COPD without chronic cough (n=11)
Number of subjects: 27
Study 33303553 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin challenge test with self-suppression attempts (CS5) for healthy participants
Number of subjects: 27
Study 33303553 — intervention group
Group type: COMPARATOR
Intervention: Capsaicin challenge test with self-suppression attempts (CS5) for CRC
Number of subjects: 27
Study 33303553 — intervention group
Group type: EXPERIMENTAL
Intervention: Objective 24-h cough frequency in COPD
Number of subjects: 27
Study 33459776 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg/day)
Number of subjects: 3730
Study 32323103 — intervention group
Group type: EXPERIMENTAL
Intervention: AE37 vaccine (VG)
Number of subjects: 456
Study 32323103 — intervention group
Group type: EXPERIMENTAL
Intervention: GP2 vaccine (VG)
Number of subjects: 456
Study 32323103 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) for AE37
Number of subjects: 456
Study 32323103 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) for GP2
Number of subjects: 456
Study 35911223 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Health Warning Labels (MHWLs)
Number of subjects: 687
Study 35911223 — intervention group
Group type: COMPARATOR
Intervention: Physical Health Warning Labels (PHWLs)
Number of subjects: 687
Study 33420583 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi (TC)
Number of subjects: 120
Study 33420583 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity resistance training (HIRT)
Number of subjects: 120
Study 33420583 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity resistance training (LIRT)
Number of subjects: 120
Study 33420583 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 35057577 — intervention group
Group type: EXPERIMENTAL
Intervention: Calanus oil (2 g CO/day)
Number of subjects: 43
Study 35057577 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 g paraffin oil/day)
Number of subjects: 43
Study 32667254 — intervention group
Group type: EXPERIMENTAL
Intervention: Sudarshan Kriya Yoga (SKY)
Number of subjects: 69
Study 32667254 — intervention group
Group type: COMPARATOR
Intervention: Wisdom On Wellness (WOW)
Number of subjects: 69
Study 33278899 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient Powder Supplementation (MNP) alongside National Micronutrient Supplement (NMS) - 3 sachets/week for 12 months
Number of subjects: 200
Study 33278899 — intervention group
Group type: COMPARATOR
Intervention: NMS alone
Number of subjects: 200
Study 33583158 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemisia supplementation (250 mg/day for six weeks)
Number of subjects: 58
Study 33583158 — intervention group
Group type: COMPARATOR
Intervention: Placebo (250 mg/day for six weeks)
Number of subjects: 58
Study 33235219 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa flavanols intake
Number of subjects: 0
Study 34475231 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 663
Study 34475231 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 663
Study 33905904 — intervention group
Group type: EXPERIMENTAL
Intervention: Occipital nerve stimulation (ONS)
Number of subjects: 96
Study 33905904 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraorbital nerve stimulation (SONS)
Number of subjects: 96
Study 33905904 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined ONS plus SONS
Number of subjects: 96
Study 33905904 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term follow-up after implantation
Number of subjects: 96
Study 33905904 — intervention group
Group type: COMPARATOR
Intervention: Trial of ONS and/or SONS
Number of subjects: 96
Study 32358413 — intervention group
Group type: EXPERIMENTAL
Intervention: Romosozumab (various doses)
Number of subjects: 402
Study 32358413 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 402
Study 33737455 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate breathing exercise
Number of subjects: 60
Study 33737455 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 60
Study 34233611 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest leukocyte count (Q1)
Number of subjects: 2898
Study 34233611 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest leukocyte count (Q4)
Number of subjects: 2898
Study 34233611 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite cardiovascular events
Number of subjects: 2898
Study 34233611 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitalization for heart failure
Number of subjects: 2898
Study 34969035 — intervention group
Group type: EXPERIMENTAL
Intervention: Hedan tablets at 4.38 g/day tid
Number of subjects: 62
Study 33293549 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggregated WMH risk variants
Number of subjects: 50970
Study 33293549 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing WMH-volume
Number of subjects: 50970
Study 33293549 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing blood pressure (BP)
Number of subjects: 50970
Study 33293549 — intervention group
Group type: EXPERIMENTAL
Intervention: WMH-volume
Number of subjects: 50970
Study 32442118 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT) applied three times
Number of subjects: 60
Study 32442118 — intervention group
Group type: COMPARATOR
Intervention: Placebo Taping (Control)
Number of subjects: 60
Study 33461965 — intervention group
Group type: EXPERIMENTAL
Intervention: green-MED diet (100 g/day Mankai, 3-4 cups/day green tea, 28 g/day walnuts)
Number of subjects: 294
Study 33461965 — intervention group
Group type: EXPERIMENTAL
Intervention: MED diet (28 g/day walnuts)
Number of subjects: 294
Study 33461965 — intervention group
Group type: COMPARATOR
Intervention: healthy dietary guidelines (HDG)
Number of subjects: 294
Study 33461965 — intervention group
Group type: EXPERIMENTAL
Intervention: green-MED diet
Number of subjects: 294
Study 33461965 — intervention group
Group type: EXPERIMENTAL
Intervention: MED diet
Number of subjects: 294
Study 35051314 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented lithium disilicate crown on a one-piece customized zirconia abutment (CEM)
Number of subjects: 34
Study 35051314 — intervention group
Group type: EXPERIMENTAL
Intervention: Screw-retained crown based on a directly veneered one-piece customized zirconia abutment (SCREW)
Number of subjects: 34
Study 35051314 — intervention group
Group type: COMPARATOR
Intervention: Overall technical complication rate
Number of subjects: 34
Study 34898444 — intervention group
Group type: EXPERIMENTAL
Intervention: Expanded version of the sexual identity question (5 additional options)
Number of subjects: 1254
Study 34898444 — intervention group
Group type: COMPARATOR
Intervention: Shorter version of the sexual identity question (3 options)
Number of subjects: 1254
Study 34898444 — intervention group
Group type: EXPERIMENTAL
Intervention: Expanded version of the sexual identity question
Number of subjects: 1254
Study 34898444 — intervention group
Group type: COMPARATOR
Intervention: Shorter version of the sexual identity question
Number of subjects: 1254
Study 35191131 — intervention group
Group type: EXPERIMENTAL
Intervention: ST-bHF (Sensory Threshold burst stimulation at High Frequency)
Number of subjects: 29
Study 35191131 — intervention group
Group type: EXPERIMENTAL
Intervention: PT-cLF (Pain Threshold, continuous Low Frequency stimulation)
Number of subjects: 29
Study 35191131 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 29
Study 33866820 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation (C‐tDCS)
Number of subjects: 45
Study 33866820 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 45
Study 35480071 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal immunochemical testing (FIT)
Number of subjects: 90513
Study 35480071 — intervention group
Group type: COMPARATOR
Intervention: Primary colonoscopy (PCOL)
Number of subjects: 90513
Study 34531823 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis treatment for 8 weeks
Number of subjects: 22
Study 34531823 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment for 8 weeks
Number of subjects: 22
Study 34531823 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis extracts in Caco-2 cells
Number of subjects: 22
Study 35234821 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 to 2 months of dual antiplatelet therapy (DAPT) followed by clopidogrel monotherapy (n=2078)
Number of subjects: 4169
Study 35234821 — intervention group
Group type: COMPARATOR
Intervention: 12 months of dual antiplatelet therapy (DAPT) with aspirin and clopidogrel (n=2091)
Number of subjects: 4169
Study 35234821 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 to 2 months of DAPT
Number of subjects: 4169
Study 35234821 — intervention group
Group type: COMPARATOR
Intervention: 12 months of DAPT
Number of subjects: 4169
Study 32947060 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesh non fixation (Group A)
Number of subjects: 798
Study 32947060 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacker mesh fixation (Group B)
Number of subjects: 798
Study 32947060 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyanoacrylic tissue glues (Histoacryl) mesh fixation (Group C)
Number of subjects: 798
Study 32947060 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 798
Study 36482620 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirabegron (M)
Number of subjects: 104
Study 36482620 — intervention group
Group type: EXPERIMENTAL
Intervention: Solifenacin (S)
Number of subjects: 104
Study 36482620 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 104
Study 32028411 — intervention group
Group type: COMPARATOR
Intervention: SPOA (postoperative sufentanil)
Number of subjects: 166
Study 32028411 — intervention group
Group type: COMPARATOR
Intervention: SPEA+SPOA (preemptive sufentanil and postoperative sufentanil)
Number of subjects: 166
Study 32028411 — intervention group
Group type: COMPARATOR
Intervention: OPEA+SPOA (preemptive oxycodone and postoperative sufentanil)
Number of subjects: 166
Study 35955126 — intervention group
Group type: EXPERIMENTAL
Intervention: HOPE intervention (four online sessions over two weeks)
Number of subjects: 174
Study 35955126 — intervention group
Group type: COMPARATOR
Intervention: Control group (online inspirational quotes)
Number of subjects: 174
Study 35955126 — intervention group
Group type: EXPERIMENTAL
Intervention: HOPE intervention
Number of subjects: 174
Study 33624330 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodic tDCS (A-tDCS) 2 mA for 20 min concurrent with speech language therapy (SLT)
Number of subjects: 18
Study 33624330 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS (S-tDCS) current started at 2 mA but decreased to 0 mA after 30 sec, concurrent with speech language therapy (SLT)
Number of subjects: 18
Study 34131093 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Medical Rehabilitation (E-MR)
Number of subjects: 229
Study 34131093 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 229
Study 32865434 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-operative wound irrigation with ceftriaxone in normal saline solution
Number of subjects: 132
Study 32865434 — intervention group
Group type: COMPARATOR
Intervention: Control group with normal saline irrigation
Number of subjects: 132
Study 32504895 — intervention group
Group type: EXPERIMENTAL
Intervention: Pervasively inactive group
Number of subjects: 579
Study 32504895 — intervention group
Group type: EXPERIMENTAL
Intervention: Pervasively active group
Number of subjects: 579
Study 32504895 — intervention group
Group type: EXPERIMENTAL
Intervention: Boom and bust group
Number of subjects: 579
Study 32504895 — intervention group
Group type: COMPARATOR
Intervention: Indeterminate group
Number of subjects: 579
Study 33919112 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based support program (ISP)
Number of subjects: 44
Study 33919112 — intervention group
Group type: COMPARATOR
Intervention: Routine postnatal care (Control)
Number of subjects: 44
Study 32342895 — intervention group
Group type: EXPERIMENTAL
Intervention: Women lifting a 6 or 12kg box
Number of subjects: 40
Study 32342895 — intervention group
Group type: COMPARATOR
Intervention: Men lifting a 6 or 12kg box
Number of subjects: 40
Study 33524876 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma transfusion and standard therapy (n = 9)
Number of subjects: 18
Study 33524876 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy alone (n = 9)
Number of subjects: 18
Study 33544247 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded exercise test (GXT) starting at 20 Watts (W), increasing by 10 W/min until volitional exhaustion.
Number of subjects: 51
Study 32545106 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced Counseling Strategy (BCS)
Number of subjects: 50
Study 32545106 — intervention group
Group type: COMPARATOR
Intervention: Control group (no BCS)
Number of subjects: 50
Study 33389308 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser turbinectomy (DLT)
Number of subjects: 42
Study 33389308 — intervention group
Group type: COMPARATOR
Intervention: Bipolar diathermy (BDT)
Number of subjects: 42
Study 35855382 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual painting therapy directed by WhatsApp (six 2-hour group sessions once a week for six weeks)
Number of subjects: 40
Study 35855382 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 40
Study 35488977 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face coaching
Number of subjects: 16
Study 35488977 — intervention group
Group type: EXPERIMENTAL
Intervention: Videoconference coaching
Number of subjects: 16
Study 35488977 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 16
Study 34018337 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal MUAC less than 23 cm (indicating underweight)
Number of subjects: 5069
Study 34018337 — intervention group
Group type: EXPERIMENTAL
Intervention: Children under two years of age
Number of subjects: 5069
Study 34018337 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal underweight status (MUAC < 23 cm)
Number of subjects: 5069
Study 32973199 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/ml phenazine application
Number of subjects: 0
Study 32973199 — intervention group
Group type: COMPARATOR
Intervention: 0.048 mg/ml hexaconazole application
Number of subjects: 0
Study 32973199 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/ml phenazine application
Number of subjects: 0
Study 32973199 — intervention group
Group type: COMPARATOR
Intervention: non-inoculated seedlings
Number of subjects: 0
Study 32973199 — intervention group
Group type: COMPARATOR
Intervention: G. boninense inoculated seedlings
Number of subjects: 0
Study 35099602 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal mesogastric fixation after laparoscopic sleeve gastrectomy
Number of subjects: 83
Study 35099602 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic sleeve gastrectomy alone without distal mesogastric fixation
Number of subjects: 83
Study 32988721 — intervention group
Group type: EXPERIMENTAL
Intervention: High-SDS diet
Number of subjects: 8
Study 32470574 — intervention group
Group type: EXPERIMENTAL
Intervention: New generic S-1 (50 mg)
Number of subjects: 70
Study 32470574 — intervention group
Group type: COMPARATOR
Intervention: Original brand-name S-1 (50 mg)
Number of subjects: 70
Study 32470574 — intervention group
Group type: EXPERIMENTAL
Intervention: New generic S-1
Number of subjects: 70
Study 32470574 — intervention group
Group type: COMPARATOR
Intervention: Original brand-name S-1
Number of subjects: 70
Study 33398464 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforced tension line (RTL) technique
Number of subjects: 124
Study 33398464 — intervention group
Group type: COMPARATOR
Intervention: Primary suture only (PSO)
Number of subjects: 124
Study 34105089 — intervention group
Group type: EXPERIMENTAL
Intervention: Prototype mini lozenge (2 or 4 mg dose)
Number of subjects: 0
Study 34105089 — intervention group
Group type: COMPARATOR
Intervention: Commercially available mini lozenge
Number of subjects: 0
Study 34105089 — intervention group
Group type: EXPERIMENTAL
Intervention: Prototype mini lozenge
Number of subjects: 0
Study 32460995 — intervention group
Group type: EXPERIMENTAL
Intervention: NIR proctoscopy
Number of subjects: 410
Study 32460995 — intervention group
Group type: COMPARATOR
Intervention: Non-NIR
Number of subjects: 410
Study 35508699 — intervention group
Group type: EXPERIMENTAL
Intervention: Vapocoolant spray
Number of subjects: 100
Study 35508699 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 100
Study 33562679 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle modification (ILSM) program including six biweekly face-to-face sessions and five biweekly phone sessions
Number of subjects: 320
Study 33562679 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle modification (ILSM) program
Number of subjects: 320
Study 33562679 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 320
Study 35852456 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezocision surgery (PS) on the randomly assigned side
Number of subjects: 23
Study 35852456 — intervention group
Group type: COMPARATOR
Intervention: Control side (no Piezocision surgery)
Number of subjects: 23
Study 33591012 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor blockers (ARBs)
Number of subjects: 297
Study 33591012 — intervention group
Group type: EXPERIMENTAL
Intervention: High mean arterial pressure target
Number of subjects: 297
Study 33591012 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ARBs)
Number of subjects: 297
Study 32067098 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyphenol-rich (PR) supplements (4.8 g/day for 4 months)
Number of subjects: 89
Study 32067098 — intervention group
Group type: COMPARATOR
Intervention: Polyphenols-free (PF) supplements (4.8 g/day for 4 months)
Number of subjects: 89
Study 35576915 — intervention group
Group type: EXPERIMENTAL
Intervention: Active transcutaneous vagus nerve stimulation (tVNS)
Number of subjects: 39
Study 35576915 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 39
Study 33901452 — intervention group
Group type: EXPERIMENTAL
Intervention: Double Thread Suspension (DTS)
Number of subjects: 60
Study 33901452 — intervention group
Group type: COMPARATOR
Intervention: Traditional procedure (TRA)
Number of subjects: 60
Study 33901452 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 33368803 — intervention group
Group type: EXPERIMENTAL
Intervention: Long working hours (≥52 hours/week)
Number of subjects: 4197
Study 33368803 — intervention group
Group type: COMPARATOR
Intervention: Standard working hours (40 hours/week)
Number of subjects: 4197
Study 33368803 — intervention group
Group type: EXPERIMENTAL
Intervention: Presenteeism
Number of subjects: 4197
Study 33368803 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower household income group
Number of subjects: 4197
Study 34526071 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored diet and oral health advice
Number of subjects: 250
Study 34526071 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 250
Study 32608554 — intervention group
Group type: EXPERIMENTAL
Intervention: MNS treatment group (N = 30)
Number of subjects: 60
Study 32608554 — intervention group
Group type: COMPARATOR
Intervention: Control group (N = 30)
Number of subjects: 60
Study 35592818 — intervention group
Group type: COMPARATOR
Intervention: Continuous infusion (CI) group received 0.2% ropivacaine 4 mL/h
Number of subjects: 88
Study 35592818 — intervention group
Group type: COMPARATOR
Intervention: PIBI1 group received intermittent 0.2% ropivacaine boluses at 4 mL/h
Number of subjects: 88
Study 35592818 — intervention group
Group type: EXPERIMENTAL
Intervention: PIBI2 group received intermittent 0.2% ropivacaine boluses at 8 mL/2 h
Number of subjects: 88
Study 35592818 — intervention group
Group type: EXPERIMENTAL
Intervention: PIBI3 group received intermittent 0.2% ropivacaine boluses at 12 mL/3 h
Number of subjects: 88
Study 34269370 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus/helveticus probiotic
Number of subjects: 133
Study 34269370 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study 32302757 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Family Navigation (FN)
Number of subjects: 40
Study 32302757 — intervention group
Group type: COMPARATOR
Intervention: Modified usual care (UC)
Number of subjects: 40
Study 35354306 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial shunt device
Number of subjects: 626
Study 35354306 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 626
Study 33785415 — intervention group
Group type: EXPERIMENTAL
Intervention: Sjögren syndrome
Number of subjects: 535
Study 33785415 — intervention group
Group type: EXPERIMENTAL
Intervention: Facial rosacea
Number of subjects: 535
Study 33785415 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis
Number of subjects: 535
Study 33785415 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral artery disease
Number of subjects: 535
Study 33785415 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily smoking history
Number of subjects: 535
Study 33785415 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroid dysfunction
Number of subjects: 535
Study 33785415 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteoarthritis
Number of subjects: 535
Study 33785415 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 535
Study 33785415 — intervention group
Group type: EXPERIMENTAL
Intervention: Irritable bowel syndrome
Number of subjects: 535
Study 33785415 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypercholesterolemia
Number of subjects: 535
Study 33785415 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 535
Study 33785415 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertriglyceridemia
Number of subjects: 535